Who you actually work with.

Founder

---

Jason Spitz

Founder & Principal

Jason founded Tilth Health Strategies after more than three decades in pharmaceutical and biotech commercial leadership, most recently as Chief Commercial Officer at ARSTAT Pharmaceuticals, where he led commercial strategy for a Phase III-ready women's health candidate. His work spans women's health, oncology and hematology, and allergy and respiratory medicine, on both sides of the size divide: a global pharmaceutical business, and clinical-stage companies preparing a first launch.

He spent nine years at TherapeuticsMD building the commercial organization behind three FDA-approved women's health products: IMVEXXY, BIJUVA, and ANNOVERA. He owned cross-functional launch readiness for all three, alongside marketing, corporate communications, and investor relations. In the same period he built vitaPearl into a prenatal vitamin franchise generating over $20 million in revenue, founded the company's in-house advertising agency, and ran patient recruitment for the Phase 3 REJOICE and REPLENISH trials.

Earlier, as General Manager for Canada at MGI Pharma, he stood up the company's first subsidiary outside the US and exceeded its sales and EBIT targets, directing worldwide commercial development of the oncology and hematology franchises through MGI's 2008 acquisition by Eisai. At Aesgen he co-led the partnering and acquisition strategy that produced a merger with MGI Pharma valued in excess of $100 million. He began at Schering-Plough, where over sixteen years he moved from field sales to global oncology marketing director by way of the Nasonex brand.

He holds a BBA in Marketing from The University of Texas at Austin and an MBA in Pharmaceutical Marketing from Fairleigh Dickinson University.

He works with a small number of clients at a time, by design.